LASG ISSUES TRAFFIC ADVISORY AHEAD OF FANTI CARNIVAL. (PHOTO). #PRESS RELEASE.

Image
 LASG ISSUES TRAFFIC ADVISORY AHEAD OF FANTI CARNIVAL The Lagos State Government has announced traffic diversions and restrictions ahead of the Lagos Fanti Carnival scheduled to hold on Monday, 6th April, 2026, around Tafawa Balewa Square (TBS), Lagos Island. In a bid to ensure a seamless and hitch-free carnival procession, vehicular movement will be restricted along major adjoining roads linking TBS. Affected Routes are; King George V Road (by Mobil Filling Station), Flag House inbound TBS, Force Road inbound TBS, Onikan Roundabout inbound TBS, and WaterBoy Roundabout by Old Defence House. Additionally, all link roads to Moloney Road, such as Military Road (by Old Defence Building), Ajasa Street, Boyle Street, and Hawley Street, will be closed to traffic during the event. To ease parking challenges, designated car parks have been arranged for public use, these include; the Yoruba Lawn Tennis Club Car Park, Zone 2 Car Park (opposite Island Club along King George V Road), Museum Kit...

GSK SEEKS APPROVAL FOR WORLD'S FIRST MALARIA VACCINE.

A jogger runs past a signage for pharmaceutical giant GlaxoSmithKline (GSK) in London April 22, 2014. REUTERS/Luke MacGregor            According to sources,the company Glaxo Smith Kline {GSK} said today thursday that it is applying for regulatory approval for the world's first vaccine against malaria,designed for children in Africa.The British drugmaker said the shot called RTS,S,is intended exclusively for use outside the European union but will be evaluated by the European medicines Agency {EMA} in collaboration with World Health Organisation {WHO}.Malaria,a mosquito borne parastic disease,kills more than 600,000 people a year,mainly babies in the poorest parts of sub Saharan Africa.Experts have long hoped that scientists would be able to develop an effective vaccine against the disease,and scientists at GSK have been working on this one for 30 years.The WHO,has previously indicated it may recommend use of RTS,S from as early as 2015 if EMA drugs regulators back its license application.GSK has been developing RTS,S with the non profit PATH malaria vaccine initiative {MVI},with grant funding from the Bill and Melinda Gates foundation to MVI.The vaccine also contains an adjuvant,or booster,made by U.S biotech company Agenus,which received an undisclosed milestone payment for the regulatory submission.

Comments

Popular posts from this blog

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).

SHAKIRA COVERS WOMEN'S HEALTH MAGAZINE,APRIL ISSUE.

TINUBU ANNOUNCES ARRIVAL OF 4 U.S ATTACK HELICOPTERS. (PHOTO).